Status: current, Primitive. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1801061000168117 | idarucizumab (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1801071000168111 | idarucizumab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| idarucizumab | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| idarucizumab | has intended active ingredient | True | idarucizumab | Inferred relationship | Some | 1 |
| Praxbind 2.5 g/50 mL injection, 50 mL vial | has Australian BoSS | True | idarucizumab | Inferred relationship | Some | 1282368082 |
| Praxbind 2.5 g/50 mL injection, 50 mL vial | has intended active ingredient | True | idarucizumab | Inferred relationship | Some | 1282368082 |
| idarucizumab 2.5 g / 50 mL injection, 50 mL vial (medicinal product unit of use) | has Australian BoSS | True | idarucizumab | Inferred relationship | Some | 1705762766 |
| idarucizumab 2.5 g / 50 mL injection, 50 mL vial (medicinal product unit of use) | has intended active ingredient | True | idarucizumab | Inferred relationship | Some | 1705762766 |
This concept is not in any reference sets
FHIR